1. Home
  2. TWAV vs BGLC Comparison

TWAV vs BGLC Comparison

Compare TWAV & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TWAV

TaoWeave Inc. Common Stock

N/A

Current Price

$1.77

Market Cap

4.2M

Sector

Technology

ML Signal

N/A

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$2.10

Market Cap

5.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TWAV
BGLC
Founded
N/A
2017
Country
United States
Malaysia
Employees
7
N/A
Industry
Computer Software: Programming Data Processing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
5.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TWAV
BGLC
Price
$1.77
$2.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
58.6K
2.6K
Earning Date
05-13-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.78
EPS
N/A
N/A
Revenue
N/A
$7,424,911.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$1.92
52 Week High
$2.41
$15.19

Technical Indicators

Market Signals
Indicator
TWAV
BGLC
Relative Strength Index (RSI) 58.44 41.77
Support Level $1.65 $1.92
Resistance Level $1.89 $2.73
Average True Range (ATR) 0.14 0.05
MACD -0.01 -0.00
Stochastic Oscillator 66.67 32.26

Price Performance

Historical Comparison
TWAV
BGLC

About TWAV TaoWeave Inc. Common Stock

TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, amd operates with zero debt by maintain appropriate cash reserves.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: